Study of ONCOFID-P-B (PACLITAXEL-HYALURONIC ACID)

PHASE3RecruitingINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

December 29, 2022

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2027

Conditions
Bladder Carcinoma in Situ (CIS)
Interventions
DRUG

ONCOFID P-B (PACLITAXEL-HYALURONIC ACID)

Schedule: once a week for 12 consecutive weeks (induction phase). Patients who achieve a complete response at the end of the induction phase will enter the maintenance phase, during which ONCOFID-P-B is administered once a month for 12 months until recurrence or progression of the disease.

Trial Locations (47)

10126

RECRUITING

AOU Città della Salute e della Scienza di Torino-Ospedale le Molinette, Torino

13009

RECRUITING

Institute Paoli-Calmettes, Marseille

14004

RECRUITING

Hospital Universitario Reina Sofia, Córdoba

18014

RECRUITING

Hospital Universitario Virgen de las Nieves, Granada

20089

RECRUITING

Istituto Clinico Humanitas, Milan

20132

RECRUITING

IRCSS Ospedale San Raffaele, Milan

20133

RECRUITING

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

21287

RECRUITING

Johns Hopkins Kimmel Cancer Center, Baltimore

24125

RECRUITING

Humanitas Gavazzeni, Bergamo

28040

RECRUITING

Hospital Fundación Jimenez Diaz, Madrid

28041

RECRUITING

Hospital Universitario 12 de Octubre, Madrid

28050

RECRUITING

Centro Integral Oncologico Clara Campal, Madrid

28922

TERMINATED

Hospital Universitario Fundacion Alcorcon, Madrid

29010

RECRUITING

Hospital Universitario Virgen de la Victoria, Málaga

29425

RECRUITING

Medical University of South Carolina (MUSC), Charleston

31033

RECRUITING

Istituto Oncologico Veneto-I.R.C.C.S.-Ospedale San Giacomo, Castelfranco Veneto

33000

RECRUITING

CHU Bordeaux -Hopital Pellegrin, Bordeaux

37126

RECRUITING

Azienda Ospedaliera Universitaria Integrata Verona-Ospedale Borgo Trento, Verona

40138

RECRUITING

IRCCS Azienda Ospedaliero-Universitaria di Bologna - Policlinico di Sant'Orsola, Bologna

45212

ACTIVE_NOT_RECRUITING

TriState Urologic Services PSC Inc. dba The Urology Group, Cincinnati

46009

RECRUITING

Instituto Valenciano de Oncologia, Valencia

48013

RECRUITING

Hospital Universitario de Basurto, Bilbao

50134

RECRUITING

Azienda Ospedaliero-Universitaria Careggi, Florence

55455

RECRUITING

University of Minnesota, Minneapolis

59000

RECRUITING

CHU de Lille - Hopital Claude Huriez, Lille

63000

RECRUITING

CHU de Clermont-Ferrand - Hopital Gabriel Montpied, Clermont-Ferrand

70124

RECRUITING

Ochsner Clinic Foundation, New Orleans

73100

RECRUITING

ASL Lecce- Ospedale Vito Fazzi, Lecce

75018

RECRUITING

AP-HP Hopital Bichat-Claude Bernard, Paris

75020

TERMINATED

AP-HP Hopital Tenon, Paris

80131

RECRUITING

Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Napoli

85234

RECRUITING

Banner Health- MD Anderson Cancer Center, Gilbert

90577

RECRUITING

Centre Hospitalier Universitaire Poitiers, Poitiers

00128

RECRUITING

IFO-Istituto Nazionale dei Tumori Regina Elena, Roma

37-700

RECRUITING

Wojewodzki Szpital im Sw. Ojca Pio w Przemyslu, Oddzial Urologiczny z Pododdzialem Urologii Onkologicznej, Przemyśl

02-637

TERMINATED

Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher, Warsaw

20-090

TERMINATED

Centrum Onkologii Ziemi Lubelskiej im. sw. Jana z Dukli, Oddzial Urologiczny, Lublin

08035

RECRUITING

Vall d'Hebron Barcelona Hospital, Barcelona

08907

RECRUITING

Hospital Universitari de Bellvitge, Barcelona

08036

RECRUITING

Hospital Clinic Barcelona, Barcelona

DA2 8DA

RECRUITING

Darent Valley Hospital, Dartford

HD3 3EA

RECRUITING

Huddersfield Royal Infirmary, Huddersfield

LS9 7TF

RECRUITING

St James's University Hospital, Leeds

EC1A7BE

RECRUITING

Barts Health NHS Trust, London

PL6 8DH

RECRUITING

Derriford Hospital, Plymouth

PR2 9HT

RECRUITING

Royal Preston Hospital, Preston

SM2 5PT

RECRUITING

Royal Marsden Hospital - Surrey, Sutton

Sponsors
All Listed Sponsors
lead

Fidia Farmaceutici s.p.a.

INDUSTRY